Evaluation of carbetocin and oxytocin efficacy in prevention of postpartum hemorrhage in women after cesarean section

被引:5
|
作者
Jagielska, Iwona [1 ]
Kazdepka-Zieminska, Anita [1 ]
Kaczorowska, Anita [2 ]
Madej, Anna [1 ]
Kolossa, Tomasz [1 ]
Grabiec, Marek [1 ]
机构
[1] CM UMK, Klin Potoznictwa Chorob Kobiecych & Ginekol, PL-85168 Bydgoszcz, Poland
[2] Gabinet Lekarza Rodzinnego Bydgoszczy, NZOZ Praktyka Lekarza Rodzinnego Krzysztof Buczko, Bydgoszcz, Poland
关键词
postpartum hemorrhage; cesarean section; carbetocin; oxytocin; RANDOMIZED CONTROLLED-TRIAL; DELIVERY;
D O I
10.17772/gp/59023
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Introduction: Postpartum hemorrhage (PPH) constitutes the main cause of delivery-related maternal mortality worldwide. Identification of the risk factors, as well as knowledge about preventive measures and adequate management, allow to limit blood loss. Oxytocin, carbetocin, methylergometrine, dinoprostone, sulprostone, and misoprostol are commonly used drugs in prevention of PPH. Objectives: The aim of the study was to evaluate the efficacy of carbetocin and oxytocin in prevention of PPH after cesarean section. Material and methods: The study included 130 female patients after C-section who received 100 pg of carbetocin i.v. as a preventive agent after the surgery The control group consisted of 60 women who received 10 units of oxytocin i.v In the study the risk factors for PPH were determined, and hemoglobin and hematocrit values before and 12 hours afterbirth, as well as blood loss and the need to use other preventive and operational methods were evaluated. Results were compared between the groups. Statistical analysis was performed with the use of Statistica for hemoglobin and hematocrit values. The p-value of <= 0.05 was considered as statistically significant. Results: Risk factors for PPH occurred in almost 100% of the women with carbetocin and in 90% of the women with oxytocin. The decrease in hemoglobin and hematocrit levels was not statistically significant, although a greater drop was detected in the group with oxytocin (hemoglobin - 1.24 vs. 1.17 g%, hematocrit - 3.26 vs. 2.93%). The decrease in hematological values was not statistically significant between both groups. In the group with carbetocin, there was no need for additional pharmacological therapy or operative procedures. No adverse events in either of the groups were observed. Conclusions: 1. Carbetocin effectively prevents PPH after C-section. 2. Carbetocin seems to have high efficiency in PPH prevention in pregnant women classified to the PPH risk group. 3. Efficacy of Carbetocin in PPH prevention is higher than oxytocin.
引用
收藏
页码:689 / 693
页数:5
相关论文
共 50 条
  • [31] A randomized controlled trial on the comparison of two doses of carbetocin with oxytocin for the prevention of postpartum hemorrhage (concert trial)
    Balogun, Rasheedat O.
    Lawal, Olatunji O.
    Bello, Yusuf O.
    Odedele, Tolulope M.
    Morhason-Bello, Imran O.
    Oladokun, Adesina
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2024, 50 (11) : 2046 - 2056
  • [32] Carbetocin vs oxytocin for prevention of postpartum hemorrhage after vaginal delivery A meta-analysis
    Jin, Xin-Hang
    Li, Dan
    Li, Xia
    MEDICINE, 2019, 98 (47)
  • [33] Carbetocin in prevention of postpartum hemorrhage: Experience in a tertiary medical center of Taiwan
    Chen, Chih-Yao
    Su, Yi-Ning
    Lin, Tzu-Hung
    Chang, Yi
    Horng, Huann-Cheng
    Wang, Peng-Hui
    Yeh, Chang-Ching
    Chang, Wen-Hsun
    Huang, Hsin-Yi
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2016, 55 (06): : 804 - 809
  • [34] Carbetocin versus oxytocin for the prevention of postpartum haemorrhage during caesarean section in patients at high risk of bleeding
    Delavallade, Melanie
    Vaunois, Agathe
    Cellier, Mathilde
    Boukerfa-Bennacer, Yasmine
    Chauleur, Celine
    Raia-Barjat, Tiphaine
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2024, 300 : 206 - 210
  • [35] Carbetocin for prevention of postcesarean hemorrhage in women with severe preeclampsia: a before-after cohort comparison with oxytocin
    Nucci, B.
    Aya, A. G. M.
    Aubry, E.
    Ripart, J.
    JOURNAL OF CLINICAL ANESTHESIA, 2016, 35 : 321 - 325
  • [36] Carbetocin vs oxytocin for the prevention of postpartum hemorrhage in grand multiparous patients: a randomized controlled trial
    Reyes, O. A.
    CLINICA E INVESTIGACION EN GINECOLOGIA Y OBSTETRICIA, 2011, 38 (01): : 2 - 7
  • [37] Double-blind comparison of carbetocin versus oxytocin in prevention of uterine atony after cesarean section
    Dansereau, J
    Joshi, AK
    Helewa, ME
    Doran, TA
    Lange, IR
    Luther, ER
    Farine, D
    Schulz, ML
    Horbay, GLA
    Griffin, P
    Wassenaar, W
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 180 (03) : 670 - 676
  • [38] Carbetocin versus oxytocin after caesarean section: similar efficacy but reduced pain perception in women with high risk of postpartum haemorrhage
    De Bonis, Maria
    Torricelli, Michela
    Leoni, Licia
    Berti, Paolo
    Ciani, Valentina
    Puzzutiello, Rosa
    Severi, Filiberto Maria
    Petraglia, Felice
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2012, 25 (06) : 732 - 735
  • [39] Use of carbetocin in prevention of uterine atony during cesarean section. Comparison with oxytocin
    Triopon, G.
    Goron, A.
    Agenor, J.
    Aya, G. A.
    Chaillou, A. -L.
    Begler-Fonnier, J.
    Bousquet, P. -J.
    Mares, P.
    GYNECOLOGIE OBSTETRIQUE & FERTILITE, 2010, 38 (12): : 729 - 734
  • [40] Efficacy of carbetocin in the prevention of postpartum hemorrhage: a systematic review and Bayesian meta-analysis of randomized trials
    Kalafat, Erkan
    Gokce, Ali
    O'Brien, Pat
    Benlioglu, Can
    Koc, Acar
    Karaaslan, Onur
    Khalil, Asma
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2021, 34 (14) : 2303 - 2316